Skip to main content

Table 2 Psychological characteristics of the two groups as result from the clinical interview based on SCID-5-CV

From: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study

 

Responders

n (%)

Non Responders

n (%)

p

Personality disorders

21 (40%)

18 (82%)

0.001

Cluster A

1 (2%)

0 (0%)

0.70

 Paranoid

1 (2%)

1 (5%)

0.50

 Schizoid

0 (0%)

0 (0%)

 Schizotypal

0 (0%)

0 (0%)

Cluster B

6 (12%)

4 (18%)

0.34

 Histrionic

2 (4%)

0 (0%)

0.49

 Narcissistic

2 (4%)

1 (5%)

0.65

 Antisocial

0 (0%)

0 (0%)

 Borderline

3 (6%)

3 (14%)

0.23

Cluster C

19 (37%)

17 (77%)

0.001

 Avoidant

5 (9%)

5 (23%)

0.12

 Dependent

4 (8%)

3 (14%)

0.33

Obsessive-compulsive

19 (36%)

15 (68%)

0.01

Mood disorders

26 (49%)

11 (50%)

0.57

Anxiety disorders

32 (60%)

20 (90%)

0.007

  1. Significant differences are bolded. SCID-5-CV The Structured Clinical Interview for DSM-5 Clinician Version